| Glycosaminoglycan and Proteoglycan‐Based Biomaterials: Current Trends and Future Perspectives J Rnjak‐Kovacina, F Tang, JM Whitelock, MS Lord Advanced healthcare materials 7 (6), 1701042, 2018 | 72 | 2018 |
| The multifaceted roles of perlecan in fibrosis MS Lord, F Tang, J Rnjak-Kovacina, JGW Smith, J Melrose, JM Whitelock Matrix Biology 68, 150-166, 2018 | 56 | 2018 |
| Plasma ion implantation of silk biomaterials enabling direct covalent immobilization of bioactive agents for enhanced cellular responses A Kondyurin, K Lau, F Tang, B Akhavan, W Chrzanowski, MS Lord, ... ACS applied materials & interfaces 10 (21), 17605-17616, 2018 | 49 | 2018 |
| Silk biomaterials functionalized with recombinant domain V of human perlecan modulate endothelial cell and platelet interactions for vascular applications J Rnjak-Kovacina, F Tang, JM Whitelock, MS Lord Colloids and Surfaces B: Biointerfaces 148, 130-138, 2016 | 42 | 2016 |
| A Biomimetic Approach toward Enhancing Angiogenesis: Recombinantly Expressed Domain V of Human Perlecan Is a Bioactive Molecule That Promotes Angiogenesis and Vascularization … X Lin, F Tang, S Jiang, H Khamis, A Bongers, JM Whitelock, MS Lord, ... Advanced Science, 2000900, 2020 | 33 | 2020 |
| Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion F Tang, MS Lord, WB Stallcup, JM Whitelock The Journal of Biochemistry 163 (5), 399-412, 2018 | 33 | 2018 |
| Microchannels are an architectural cue that promotes integration and vascularization of silk biomaterials in vivo F Tang, XD Manz, A Bongers, RA Odell, H Joukhdar, JM Whitelock, ... ACS Biomaterials Science & Engineering 6 (3), 1476-1486, 2020 | 32 | 2020 |
| Recombinant domain V of human perlecan is a bioactive vascular proteoglycan J Rnjak‐Kovacina, F Tang, X Lin, JM Whitelock, MS Lord Biotechnology journal 12 (12), 1700196, 2017 | 28 | 2017 |
| Bioengineered human heparin with anticoagulant activity MS Lord, B Cheng, F Tang, JG Lyons, J Rnjak-Kovacina, JM Whitelock Metabolic Engineering 38, 105-114, 2016 | 28 | 2016 |
| Biomimetic silk biomaterials: perlecan-functionalized silk fibroin for use in blood-contacting devices K Lau, A Waterhouse, B Akhavan, L Gao, HN Kim, F Tang, JM Whitelock, ... Acta Biomaterialia 132, 162-175, 2021 | 26 | 2021 |
| ROS-mediated anti-angiogenic activity of cerium oxide nanoparticles in melanoma cells JM Yong, L Fu, F Tang, P Yu, RP Kuchel, JM Whitelock, MS Lord ACS Biomaterials Science & Engineering 8 (2), 512-525, 2022 | 22 | 2022 |
| Silk fibroin photo-lyogels containing microchannels as a biomaterial platform for in situ tissue engineering M Baptista, H Joukhdar, CR Alcala-Orozco, K Lau, S Jiang, X Cui, S He, ... Biomaterials Science 8 (24), 7093-7105, 2020 | 18 | 2020 |
| Defining the versican interactome in lung health and disease F Tang, JE Brune, MY Chang, SR Reeves, WA Altemeier, CW Frevert American Journal of Physiology-Cell Physiology 323 (2), C249-C276, 2022 | 12 | 2022 |
| Engineered short forms of perlecan enhance angiogenesis by potentiating growth factor signalling HN Kim, Z Elgundi, X Lin, L Fu, F Tang, ESX Moh, MS Jung, ... Journal of Controlled Release 362, 184-196, 2023 | 6 | 2023 |
| Inter-alpha-trypsin inhibitor (IαI) and hyaluronan modifications enhance the innate immune response to influenza virus in the lung F Tang, SR Reeves, JE Brune, MY Chang, CK Chan, P Waldron, ... Matrix Biology 126, 25-42, 2024 | 2 | 2024 |
| Sulfation Signatures of Chondroitin Sulfate Proteoglycans Unveiled Through Mass Spectrometry and Nanopore Sequencing X Zhou, F Tang, CW Frevert, J Nivala, K Alonge GLYCOBIOLOGY 33 (11), 1067-1067, 2023 | | 2023 |
| The multifaceted roles of perlecan in fibrosis J Melrose, M Lord, J Rnjak-Kovacina, J Smith, F Tang, JM Whitelock Elsevier, 2018 | | 2018 |
| Plasma Immersion Ion Implantation Treatment of Silk Biomaterials Enhances Biological Function F Tang, K Lau, A Kondyurin, MS Lord, J Whitelock, M Bilek, ... TISSUE ENGINEERING PART A 22, S129-S129, 2016 | | 2016 |
| Domain V of Perlecan Covalently Immobilized on Silk Biomaterials Modulates Endothelial Cell and Platelet Interactions for Vascular Applications J Rnjak-Kovacina, F Tang, JM Whitelock, MS Lord TISSUE ENGINEERING PART A 22, S20-S21, 2016 | | 2016 |
| Bioengineering of Human Heparin: A Next Generation Anti‐coagulant J Whitelock, B Cheng, F Tang, G Lyons, M Lord The FASEB Journal 30, 1070.5-1070.5, 2016 | | 2016 |
John WhitelockUniversity of New South Wales在 unsw.edu.au 的电子邮件经过验证
